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Abstract
Background:  Entry of HIV-1 into human lymphoid requires activities of viral envelope
glycoproteins gp120 and gp41, and two host-cell proteins, the primary receptor CD4 and a
chemokine co-receptor. In addition, a third cell-surface protein called protein disulfide isomerase
(PDI) is found to play a major role in HIV-1 entry. PDI is capable of mediating thio-disulfide
interchange reactions and could enable the reduction of gp120 disulfide bonds, which triggers the
major conformational changes in gp120 and gp41 required for virus entry. In this scenario,
inhibition of HIV-1 entry can be brought about by introducing agents that can block thiol-disulfide
interchange reaction of cell surface PDI. There have been studies with agents that inhibit PDI
activity, but the exact mode of binding remains to be elucidated; this might provide insights to
develop new drugs to target PDI. This study attempts to perceive the mode of binding of
dithionitrobenzoic acid (DTNB), and its structurally related compounds on PDI enzyme.
Results: We performed molecular docking simulation with six different inhibitors (ligand), which
includes DTNB, NSC695265, thionitrobenzoic acid, 2-nitro-5-thiocyanobenzoic acid, 2-nitro-5-
sulfo-sulfonyl-benzoic acid and NSC517871 into the redox-active site [C37-G38-H39-C40] of the
PDI enzyme and the activity was inferred by redox inhibitory models. All ligands showed favorable
interactions and most of them seemed to bind to hydrophobic amino acids Ala34, Trp36, Cys37,
Cys40, His39, Thr68 and Phe80. The redox inhibitory conformations were energetically and
statistically favored and supported the evidence from wet laboratory experiments reported in the
literature.
Conclusion: We demonstrated that in silico docking experiment can be effectively carried out to
recognize the redox inhibitory models of PDI with inhibitor molecules. Interestingly we found that
number of docked clusters with each ligand varies in the range of five to eight and conveys that the
binding specificity of each inhibitor varies for PDI. We also identified that Cys37 of the enzyme plays
an important role in hydrogen bonding with inhibitors. This residue can be considered to being an
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active site for anti-HIV drug design. Therefore, by inhibiting PDI, one can, not only prevent the viral
entry but also circumvent the problem of viral resistance
Background
The entry of virus into target cell represents one of the
most attractive targets in the search for new drugs to treat
HIV infection. The entry of HIV-1 into target cells requires
the cooperation of the viral envelope glycoproteins gp120
and gp41, and of two host-cell proteins, the primary
receptor CD4 and a chemokine co-receptor [1]. Several
agents have been developed to target these key regulatory
proteins that are essential for HIV replication. Several of
them are in clinical trials and one of them has been
approved by the FDA for clinical use. Therefore, drugs tar-
geting HIV-1 entry are an exiting prospect in terms of pre-
vention of AIDS. Recently another cell-surface protein was
found to be involved in HIV-1 entry, the oxidoreductase
protein disulfide isomerase (PDI, E.C. 5.3.4.1) which cat-
alyzes thiol-disulfide interchange reactions [2,3]. It is
present mostly in the endoplasmic reticulum and act as
oxidase to forms disulfide bonds in nascent proteins and
assists in protein folding [4]. It also occurs at the surface
of mammalian cells, where it acts as a reductase to cleave
disulfide bonds of proteins attached to the cell [5]. Its
redox function is based on the presence of two cysteine
residues in its active sites Cys-Gly-His-Cys (CXXC). When
the cysteine of CXXC bears two cysteinyl thiols, it breaks
neighboring disulfide bonds. In the event of HIV-1 entry,
the viral glycoprotein gp120 attaches the virus to the cell
by binding to its receptor CD4 which also contains
disulfide bonds. After CD4 binding, various gp120
domains interact with the enzyme PDI and the chemok-
ine co-receptors forms a PDI-CD4-gp120-chemokine
complex. PDI can reach the complex and reduce disulfide
bonds in gp120, which causes key conformational
changes in gp120 and activate gp41 for the fusogenic
potential of the viral envelope [3]. It has been shown that
inhibition of HIV-1 entry can be brought about by intro-
ducing membrane impermeant sulfhydryl agents that can
block the redox function of PDI [2]. These agents will stop
the generation of two free thiols in a Gp120 and an oxi-
dized form of CXXC motif in PDI.
It was reported that the membrane-impermeant thiol rea-
gent dithionitrobenzoic acid (DTNB) causes 100% inhibi-
tion of soluble PDI activity at 1.0 mM concentration [2,3].
The exact mode of binding interaction is yet to be eluci-
dated and this would give more insights into develop-
ment of new effective drugs that target PDI activity.
Therefore, this necessitates a rational study on the mode
of binding of the inhibitors to PDI. This can be achieved
by molecular docking studies to determine whether two
molecules interact and to find the orientation that maxi-
mizes this interaction as well as minimizing the total
energy of the interaction complex. Predicting the mode of
protein interaction with other molecules promises deduc-
tion of protein function and the enhancement of drug dis-
covery. A tangible example can be seen with HIV-1
Protease [6]. The current study attempts to find the mode
of binding of DTNB and its related compounds on PDI.
The Accelrys Discovery Studio and AutoDock 4.0 [7] were
used to study the interaction. Therefore, by inhibiting
PDI, one can not only prevent the viral entry, but also cir-
cumvent the problem of viral resistance because PDI is a
host protein [8].
Methods
The set of ligand molecules studied in this work include
dithionitrobenzoic acid (DTNB) [PubChem:6254] and its
structurally similar bioactive compounds such as
NSC695265 (5-(3-carboxy-4-nitro-phenyl) sulfonyl-2-
nitrobenzoic acid) [PubChem:393411], Thionitrobenzoic
acid [PubChem:123648], 2-nitro-5-thiocyanobenzoic
acid [PubChem:92266], 2-nitro-5-sulfo-sulfonyl-benzoic
acid [PubChem:128933] and NSC517871 (2-(2-carboxy-
4-nitro-phenyl) disulfonyl-5-nitrobenzoic acid)
[PubChem:351009]. These ligand molecules were
retrieved from NCBI-PubChem Compound database
[9,10]. The structure of these compounds is shown in Fig-
ure 1. The three dimensional structure of second thiore-
doxin-like domain of human Protein disulfide-isomerase
[PDB: 1X5C] was obtained from Protein Data Bank (PDB)
[11,12]. This structure was determined using NMR exper-
imental method [13,14]. The energy of the ligand mole-
cules and target PDI were minimized in Steepest Descent
followed by Conjugate Gradient method using Accelrys
Discovery Studio (Version 1.7, Accelrys Software Inc.), the
most comprehensive suite of modeling and simulation
solutions for drug discovery available. Each of the mini-
mization methods were carried out with CHARMm force
field.
In order to carry out the docking simulation, we used the
AutoDock 4.0 suite as molecular-docking tool [15]. It is
suitable software for performing automated docking of
ligands to their macromolecular receptors. Typically, the
ligands are substrates or drug candidates and the macro-
molecule is a protein of known three dimensional struc-
tures. In this docking simulation, we used semi-flexible
docking protocols. In which the target protein PDI was
kept as rigid. The ligands being docked were kept flexible,
in order to explore an arbitrary number of torsional
degrees of freedom in addition to the six spatial degrees ofBMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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Two dimensional molecular structures of the ligands/inhibitors Figure 1
Two dimensional molecular structures of the ligands/inhibitors. (A) dithionitrobenzoic acid (DTNB), (B) NSC695265 
(5-(3-carboxy-4-nitro-phenyl) sulfonyl-2-nitrobenzoic acid), (C) Thionitrobenzoic acid, (D) 2-nitro-5-thiocyanobenzoic acid, (E) 
2-nitro-5-sulfo-sulfonyl-benzoic acid and (F) NSC517871BMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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freedom spanned by the translational and rotational
parameters. The Graphical User Interface program "Auto-
Dock Tools" was used to prepare, run, and analyze the
docking simulations. Kollman united atom charges, sol-
vation parameters and polar hydrogens were added into
the receptor PDB file for the preparation of protein in
docking simulation. This PDI enzyme structure does not
have any water molecules and/or ligands to remove from
its PDB file and make a free receptor. Since ligands are not
peptides, Gasteiger charge was assigned and then non-
polar hydrogens were merged. The rigid roots of each lig-
and were defined automatically instead of picking manu-
ally. The amide bonds were made non-rotatable. All
rotable dihedrals in the ligands were assigned with the
help of auxiliary program Auto-Tors and were allowed to
rotate freely. AutoDock requires pre-calculated grid maps,
one for each atom type, present in the ligand being
docked and its stores the potential energy arising from the
interaction with macromolecule. This grid must surround
the region of interest in the macromolecule. In the present
study, the binding site was selected based on the amino
acid residues, which are involved in redox function and is
required for HIV entry into the host cell. Therefore, the
grid was centered in the catalytic active region of redox-
active Cys-Gly-His-Cys motif and includes all amino acid
residues that surround active site. The grid box size was set
at 40, 40, and 40 A° (x, y, and z), though it was changed
depending on the ligand size. AutoGrid 4.0 Program, sup-
plied with AutoDock 4.0 was used to produce grid maps.
The spacing between grid points was 0.375 angstroms.
The Lamarckian Genetic Algorithm (LGA) was chosen to
search for the best conformers. During the docking proc-
ess, a maximum of 10 conformers was considered for each
compound. The population size was set to 150 and the
individuals were initialized randomly. Maximum number
of energy evaluation was set to 250000, maximum
number of generations 1000, maximum number of top
individual that automatically survived set to 1, mutation
rate of 0.02, crossover rate of 0.8, Step sizes were 0.2 Å for
translations, 5.0° for quaternions and 5.0° for torsions.
Cluster tolerance 0.5A°, external grid energy 1000.0, max
initial energy 0.0, max number of retries 10000 and 10
LGA runs were performed. All the AutoDock docking runs
were performed in Intel Pentium PD-925 CPU @ 3.0 GHz
of HCL infosystem origin, with 2 GB DDR RAM. Auto-
Dock 4.0 was compiled and run under Windows XP oper-
ating system.
Results and discussion
Existing NMR structure of protein disulfide isomerase was
downloaded from PDB [PDB: 1X5C]. An examination of
this NMR structure for the domain of PDI showed the
cysteines in their CXXC motifs (C37-G38-H39-C40) are
in the form of free thiols. At the cell surface, this isomerase
predominantly acts as reductase leads to the cleavage of
disulfide bonds and production of free thiols in the inter-
acting protein (gp120). The criteria which we have fol-
lowed in the selection of ligands includes only targeting
cell surface PDI by using membrane impermeant sulfhy-
dryl inhibitors. Investigational membrane impermeant
PDI inhibitors include thiol blockers such as DTNB,
NSC695265, thionitrobenzoic acid, 2-nitro-5-thiocy-
anobenzoic acid, 2-nitro-5-sulfo-sulfonyl-benzoic acid
and NSC517871 were retrieved from PubChem database.
All the ligands (inhibitors) and PDI structures were con-
firmed to have minimized energy based on the final
potential energy obtained from the results as shown in the
Table 1. The potential energy value of all ligands was
below -100 kcal/mol. These ligand molecules have the
potential to change the original states of it is into a system
of binding state in a target PDI molecule when the energy
is released. The potential energy of PDI was -7435. 981
kcal/mol. Molecular docking simulations were conducted
with the AutoDock 4.0 software suite. 10 Docking runs
were performed for each of the six different ligands into
redox-active site [C37-G38-H39-C40] of PDI protein. For
each docking simulation, the activity inferred by redox
inhibitory docked models, in which the docked conform-
ers of ligands and PDI would permit redox active interac-
tion (CXXC motif interaction) and matched with the wet
lab experimental observation results of inhibition [2]. To
Table 1: Minimized energy values for selected ligand molecules
Molecules Energy levels after Steepest Descent (kcal/mol) Energy levels after Conjugate Gradient (kcal/mol)
Int PE PE VdwE EE Int PE PE VdwE EE
Dithionitrobenzoic Acid 331.53835 -34.79587 6.27249 -69.98690 -34.79579 -45.38513 6.89156 -77.57011
NSC695265 180.65760 -28.82409 5.10126 -71.60158 -28.82403 -39.42310 6.24088 -81.42580
Thionitrobenzoic acid 79.01217 -17.88183 4.14326 -33.77424 -17.88183 -17.94201 4.03114 -34.15011
2-nitro-5-thiocyanobenzoic 
acid
46.04640 -21.75786 4.86418 -39.49934 -21.75786 -24.37826 3.72729 -40.29113
2-nitro-5-sulfo-sulfonyl-
benzoic acid
71.29484 -14.62018 3.70143 -30.79463 -14.62018 -22.80483 2.65945 -38.26210
NSC517871 200.70255 -62.11036 5.20568 -87.42863 -62.11034 -96.68291 8.13743 -118.83934BMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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verify the accuracy of the AutoDock 4.0 results, we also
considered some top clusters of conformations/orienta-
tions in addition to the best scored one. Here, the docking
accuracy was evaluated in terms of the root mean square
deviation (RMSD) between the docked position and the
experimentally determined position for the ligand. In this
molecular docking study, prediction was considered suc-
cessful if the RMSD value is less then 2.0 Å for the best-
scored conformation [16]. The redox inhibitory confor-
mations were energetically and statistically validated.
Docking of DTNB into PDI
As shown in Table 2, the docking results are ranked
according to the ascent of the binding energies for each of
Table 2: Summary of docking for all six ligands into protein disulfide isomerase
Docking statistics (RMSD-tolerance of 2.0 Å)
Molecules Number of clusters Cluster rank Lowest binding energy 
(kcal/mol
Number of runs Inferred reactivity
DTNB 8 1 -2.56 2 Non-redox Inhibitory
2 +17.08 1 Non-redox Inhibitory
3 +29.52 1 Non-redox Inhibitory
4 +37.83 1 Non-redox Inhibitory
5 +57.26 2 Redox Inhibitory
+64.98 (2nd sub-rank) Redox Inhibitory
6 +76.30 1 Non-redox Inhibitory
7 +82.38 1 Non-redox Inhibitory
8 +90.87 1 Non-redox Inhibitory
NSC695265 5 1 -2.81 1 Non-redox Inhibitory
2 +3.24 1 Non-redox Inhibitory
3 +5.64 5 Non-redox Inhibitory
4 +8.43 2 Non-redox Inhibitory
+9.77(2nd sub-rank) Redox Inhibitory
5 +9.61 1 Non-redox Inhibitory
Thionitrobenzoic acid 6 1 +7.33 1 Non-redox Inhibitory
2 +9.46 4 Redox Inhibitory
+9.68 (2nd sub-rank) Redox Inhibitory
3 +12.48 1 Non-redox Inhibitory
4 +21.07 2 Non-redox Inhibitory
5 +34.05 1 Non-redox Inhibitory
6 +36.25 1 Non-redox Inhibitory
2-nitro-5-thiocyanobenzoic 
acid
6 1 +10.52 2 Non-redox Inhibitory
2 +14.16 1 Non-redox Inhibitory
3 +24.91 2 Non-redox Inhibitory
4 +25.42 3 Non-redox Inhibitory
5 +31.31 1 Non-redox Inhibitory
6 +72.55 1 Redox Inhibitory
2-nitro-5-sulfo-sulfonyl-
benzoic acid
8 1 +1.45 1 Non-redox Inhibitory
2 +3.40 1 Non-redox Inhibitory
3 +5.56 1 Non-redox Inhibitory
4 +5.82 1 Non-redox Inhibitory
5 +6.19 1 Redox Inhibitory
6 +8.48 3 Non-redox Inhibitory
7 +23.72 1 Non-redox Inhibitory
8 +44.52 1 Redox Inhibitory
NSC517871 7 1 -1.12 2 Non-redox Inhibitory
2 +0.26 1 Non-redox Inhibitory
3 +2.77 2 Non-redox Inhibitory
+13.37 (2nd sub-rank) Redox Inhibitory
4 +10.25 1 Non-redox Inhibitory
5 +10.67 1 Non-redox Inhibitory
6 +11.01 1 Non-redox Inhibitory
7 +12.32 2 Non-redox InhibitoryBMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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the ligands investigated. Docking simulation of DTNB
into the redox active site of the PDI produced eight clus-
ters of conformers using RMSD-tolerance of 2.0 Å out of
10 docking runs (Table 2). The conformation of the #1
ranked cluster was favored in that structure and repeated
two times out of 10 runs. Inspection of this conformation
showed that it could explain the non-redox inhibitory
mode of PDI (structure not shown), since docked region
was out of redox active site. The conformation of the #5
ranked cluster of DTNB in the PDI was also highly ener-
getically and statistically favored. In which, it was
observed that two redox inhibitory docking modes were
found in same cluster rank, which would explain the
inhibitor effect of the enzyme. In these two conforma-
tions, there were, three, two hydrogen bonds formed,
respectively (Table 3). The thiol group of Cys37 and back-
bone-oxygen atom of Phe80 in PDI enzyme interacts with
the two different atom of sulfur (S2 and S1) in DTNB to
form multiple hydrogen bonds in both the two conforma-
tions with a bond length of approximately 2.0 Å, respec-
tively. In addition, side chain nitrogen atom of Arg101
was also involved in the hydrogen bond interaction with
O3 atom of DTNB in the lowest binding energy complex
of #5 ranked clusters. The DTNB was also made additional
van der Waals forces with the residues Ala34, Trp36,
His39, Cys40, and Pro81 in the scaling factor around 1.00
Å to further stables the interaction (Figure 2A). The lowest
binding energy of the docked complex was 57.26 kcal/
mol. The lowest cluster root mean square deviation
(RMSD) between the docked conformation and the con-
formation in the crystal structure was 1.66 Å. The confor-
mations of other clusters of DTNB in PDI were all non-
redox inhibitory model. In these instances, DTNB was
bound in similar fashion to that seen with cluster rank #1.
Docking of NSC695265 into PDI
Docking simulation of NSC695265 (5-(3-carboxy-4-
nitro-phenyl) sulfonyl-2-nitrobenzoic acid) into PDI
resulted in five clusters of conformers (Table 2). The
docked models of all the clusters appeared non-redox
inhibitory mode, since docked region of the compound in
out side of the redox active site. In detailed inspection of
sub ranked cluster conformations, it was observed that the
second sub-rank of #4 cluster represented redox inhibi-
tory mode. In this docked complex, side chain NH group
of Trp36 and OH11 group of NSC695265 acts as hydro-
gen bond donors to make multiple hydrogen bonds with
sulfur atom of Cys37 and O6 atom of NSC695265,
respectively. The bond distance between donors and
acceptors atoms of hydrogen bond was in approximately
2.1 Å (Table 3). In addition to hydrogen bonds, residues
Ala 34, His39, Thr68, Ser79, and Phe80 were involved in
van der Waals interactions further stabilized the ligand
(Figure 2B). Among these residues Ala34 and His39 were
in similar binding mode as compared to #5 ranked cluster
of DTNB docking. The conformations of the #3 ranked
cluster of NSC695265 in PDI were generated five more
sub-ranked complexes with non-redox inhibitory modes.
Table 3: Molecular interactions of all six ligands into protein disulfide isomerase




Length of hydrogen 
bond (Å)
Residues involved 
in van der Waals 
interaction 
(Scaling Factor = 
1.00 Å)

















PDI:A:CYS37:SG LIGAND3::MOL1:O1 2.109 TRP36, PHE80 9.46





LIGAND4::MOL1:H5 PDI: A: PHE80: O 1.927
2-nitro-5-sulfo-
sulfonyl-benzoic acid
LIGAND5::MOL1:H22 PDI:A:CYS37:SG 2.199 ALA34, TRP36, 
GLY38, HIS39, PHE80
6.19
NSC517871 LIGAND6::MOL1:H9 PDI:A:CYS37:SG 2.025 ALA34, TRP36, 
HIS39, SER67, THR68, 
PHE80
13.37BMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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Representative docking redox-inhibitory models of Figure 2
Representative docking redox-inhibitory models of. (A) DTNB, (B) NSC695265 (5-(3-carboxy-4-nitro-phenyl) sulfonyl-
2-nitrobenzoic acid), (C) Thionitrobenzoic acid, (D) 2-nitro-5-thiocyanobenzoic acid, (E) 2-nitro-5-sulfo-sulfonyl-benzoic acid 
and (F) NSC517871 (2-(2-carboxy-4-nitro-phenyl) disulfonyl-5-nitrobenzoic acid) into PDI enzyme. The green dot lines denote 
the hydrogen bonds. All the amino acid residues which involved in molecular interaction are shown in wire frame drawing and 
colored by atom types in which hydrogen is colored cyan, carbon gray, oxygen red, nitrogen blue, and sulfur yellow. Ligands 
are shown in stick drawing.BMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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These conformations had significantly high frequency of
non-redox docking occurrences than those of other
ranked clusters.
Docking of thionitrobenzoic acid into PDI
The ten runs of docking simulations of thionitrobenzoic
acid to PDI resulted six clusters of conformers. The confor-
mations of the ranked and sub-ranked #2 cluster were
highly favored statistically and energetically and repeated
four times (Table 2) with the high frequency of occur-
rences. Analysis of the positions and orientations of the
ligand in the docking models in relationship to the loca-
tion of the redox-avtice site indicating that the first and
second sub-ranked conformation of the #2 cluster repre-
sented redox inhibitory mode. In these two conforma-
tions, there were same atoms involved in hydrogen bond
formation. In which, thiol group of Cys37 participated in
hydrogen bond formation with the O1 atom of the ligand
(Table 3). As a result, conformations were having similar
binding energies with similar bond length of 2.1 Å. In
addition to Cys37 residue, the thionitrobenzate was held
in position by van der Waals forces with the residues
Trp36 and Phe80 (Figure 2C). These same residues were
participated in the redox inhibitory mode of DTNB in PDI
enzyme. The cluster conformers of the other ranked clus-
ters were in non-redox inhibitory modes.
Docking of 2-nitro-5-thiocyanobenzoic acid into PDI
The results for docking 2-nitro-5-thiocyanobenzoic acid
into PDI enzyme are given in Table 2. One redox inhibi-
tory mode was found (cluster #6, Figure 2D) with the 2-
nitro-5-thiocyanobenzoic acid, which could explain the
redox inhibitory activity of the enzyme. This conforma-
tion was energetically favored. The amino acid residues of
PDI involved in the interaction with 2-nitro-5-thiocy-
anobenzoic acid, which were mostly similar to those resi-
dues involved in the redox-inhibitory mode of DTNB in
PDI (Table 3). In the conformation of #6 ranked cluster,
there were four hydrogen bonds formed between the 2-
nitro-5-thiocyanobenzoic acid with residues Cys37,
Cys40, Phe80 of PDI target with binding energy of 72.55
kcal/mol. In is interesting to note that the redox-active
sites of Cys37 and Cys40 were both involved in hydrogen
bond formation. In addition, S-H and S atoms of Cys37
itself acts as hydrogen bond donor and acceptor to inter-
act with O1 and O-H7 atoms of ligand in the formation of
hydrogen bonds, respectively. This cluster docked confor-
mation was also stabled by van der Waals with Ala34,
Trp36 and Thr68.
Docking of 2-nitro-5-sulfosulfanyl-benzoic acid into PDI
The number of docked clusters observed with 2-nitro-5-
sulfo-sulfonyl-benzoic acid for PDI was less frequency of
occurrences, since produced seven different clusters with
single conformer and one cluster (#6 ranked) with three
conformers (Table 2), indicating a decreased specificity of
this ligand with PDI. There were two clusters (#5 and # 8
ranked) of conformers appeared as redox-active mode out
of eight clusters generated. The lowest binding energy of #
5 ranked clusters was observed with 6.19 kcal/mol and it
was significantly lower than the other ligands docked.
There was a single hydrogen bond formed between elec-
tronegative atoms of sulfur in Cys37 with O-H22 group of
2-nitro-5-sulfosulfanyl-benzoic acid (Figure 2E). The resi-
dues Ala34, Trp36, Gly38, His39 and Phe80 were also
taken part in van der Waals interactions with quite same
as redox-inhibitory mode of DTNB in PDI in the scaling
factor around 1.00 Å.
Docking of NSC517871 into PDI
The docked models of clusters of NSC517871 (2-(2-car-
boxy-4-nitro-phenyl) disulfanyl-5-nitrobenzoic acid) in
PDI all appeared non-redox inhibitory mode, since the
ligand was placed far away from the redox-active binding
site. In the second sub-ranked conformation of the #3
ranked cluster, NSC517871 was bound to PDI in a fash-
ion similar to the redox inhibitory modes of DTNB, 2-
nitro-5-sulfosulfanyl-benzoic acid and NSC695265 in
PDI such that it was the quite same amino acid residues
involved in the molecular interaction (Table 3, Figure 2F).
In the hydrogen bond formation, sulfur atom of Cys37
acts as hydrogen bond acceptors to made interaction with
O-H9 group of NSC517871 with bond length of 2.0 Å as
approximately similar to 2-nitro-5-sulfo-sulfonyl-benzoic
acid docking in concern to both numbers of hydrogen
bond and bond length. The van der Waals interactions
between the PDI and NSC517871 were observed in the
residues of Ala34, Trp36, His39, Ser67, Thr68 and Phe80
in a maximum similar to those observed in the case of 2-
nitro-5-sulfo-sulfonyl-benzoic acid in PDI.
As shown in Table 3, it was observed that all the six differ-
ent ligand molecules participated in hydrogen bond for-
mation with sulphur atom of the Cys37 and/or Cys40 in
PDI. In addition to this, sulfur atom in dithionitrobenzoic
acid itself act as hydrogen bond acceptor. Sulfur atoms are
larger and have a more diffuse electron cloud than oxygen
and nitrogen. The O-H...S- hydrogen bond strength in
cysteine thiolate anion was estimated experimentally as
16.4 ± 2.0 kcal/mol [17]. This makes binding energy of
the complex in positive score. Lipinski's rule of five was
calculated for all the six ligand molecules that satisfy the
'rule-of-5' and it was found that all the ligand molecules
satisfied the rule for potent inhibitors (Table 4).
Conclusion
In this work, a molecular docking simulation study was
undertaken to investigate the binding mechanism of
DTNB and its structurally similar membrane impermea-
ble inhibitors such as DTNB, NSC695265, thionitroben-BMC Bioinformatics 2008, 9(Suppl 12):S14 http://www.biomedcentral.com/1471-2105/9/S12/S14
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zoic acid, 2-nitro-5-thiocyanobenzoic acid, 2-nitro-5-
sulfo-sulfonyl-benzoic acid and NSC517871 to the pro-
tein disulfide isomerase enzyme to enable the finding of
potential anti-HIV drugs (namely, the development of
inhibitors of surface associated PDI). We determined the
energetically favored docking sites for the inhibitors. Our
docking results explain that the numbers of clusters with
each ligand vary in the range from five to eight for PDI
enzyme (Table 2), indicating that the binding specificity
of each ligand is varying in PDI. In this study, the hydro-
gen bond makes important contributions to the interac-
tions between ligand and enzyme. From the frequency of
residue's occurrence in the formation of hydrogen bond-
ing, it is evident that Cys37 plays an important role due to
the presence of S-H group and it acts as both hydrogen
bond donor and acceptor. And Trp36, Cys40, Phe80,
Ag101 also take part in the hydrogen bonding with com-
paratively high frequency. This information could be sup-
portive for new drug design for AIDS, in which these
potential inhibitors should interact strongly with above-
mentioned residues. Cys37 is of great concern in anti-HIV
drug design, which is believed to be one of redox-active
site in PDI [2]. It is significant to have this Cys37 S-H
group locked such that its reduction function is depressed.
Therefore the above-mentioned inhibitors will block the
cleavage of disulfide bond in gp120, leading to inactive
gp41 and resistance to the entry of HIV. It was observed
that there were maximum of four hydrogen bonds formed
between PDI and the inhibitors used (Table 3). Besides
hydrogen bonding, van der Waals interactions were also
taking part in the stabilizations of inhibitors binding with
high frequency of residues such as Ala34, Trp36, Cys40,
His39, Thr68 and Phe80 in PDI. The redox-inhibitory
mode of all six inhibitors with PDI was consistent with the
laboratory experimental result of Ryser et al [2].
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